VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2014

Jun 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2014-06-01

Reporting Person: MCGLYNN MARGARET G (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-01	Stock Option	$72.14	A	20000	Acquired	2024-05-31	Common Stock (20000)	Direct

Footnotes

F1: Fully vested.